Research Topics
| Roy H DeckerSummaryAffiliation: Yale University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Role of radiotherapy in the management of merkel cell carcinoma of the skinRoy H Decker
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, USA
J Natl Compr Canc Netw 4:713-8. 2006..For select patients, primary radiotherapy is a reasonable option with a low risk for local or regional recurrence...
Advances in radiotherapy for lung cancerRoy H Decker
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520 8040, USA
Semin Respir Crit Care Med 29:285-90. 2008....- ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancerRoy H Decker
Yale University School of Medicine, New Haven, CT, USA
Am J Clin Oncol 34:537-44. 2011..The sequencing of radiotherapy and chemotherapy is discussed, along with issues regarding radiotherapy dose and fractionation, and the appropriate use of intensity modulated radiation therapy and particle therapy... - Postoperative radiation therapy for non-small cell lung cancerRoy H Decker
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Semin Thorac Cardiovasc Surg 20:184-7. 2008..Improvements in radiation technique appear to have decreased the toxicity of PORT in more modern series, presumably increasing the potential benefit... 
Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancerAnthony W Kim
Section of Thoracic Surgery, Department of Therapeutic Radiology and Radiation Oncology, Cancer Outcomes, Public Policy, and Effectiveness Research COPPER Center, Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, Connecticut 06520, USA
Ann Thorac Surg 94:895-901. 2012..However it is unclear how race, clinical, and hospital characteristics affect the surgical approach among patients undergoing resection...- Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinomaAyal A Aizer
Department of Radiation Oncology, Yale School of Medicine, New Haven, CT, USA
Int J Radiat Oncol Biol Phys 75:1344-9. 2009..To determine whether whole pelvic radiotherapy (WPRT) or prostate-only radiotherapy (PORT) yields improved biochemical disease-free survival (BDFS) in patients with advanced or aggressive prostate adenocarcinoma... - The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapyAyal A Aizer
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA
Int J Radiat Oncol Biol Phys 79:379-84. 2011..To assess the impact of pretreatment prostate volume on the development of severe acute genitourinary toxicity in patients undergoing intensity-modulated radiation therapy (IMRT) for prostate cancer... - The prognostic importance of midline involvement in oral tongue cancerShane Lloyd
Division of Otolaryngology, Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06510, USA
Am J Clin Oncol 35:468-73. 2012..To examine the importance of midline involvement and other clinicopathologic factors in predicting the rate of contralateral lymph node metastasis and survival in oral tongue squamous cell carcinoma... - Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancerJames B Yu
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut, USA
J Thorac Oncol 5:215-9. 2010..This study was performed to evaluate the clinical outcomes of surgery for stage I small cell lung cancer (SCLC)... - A prognostic index for predicting lymph node metastasis in minor salivary gland cancerShane Lloyd
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520 8040, USA
Int J Radiat Oncol Biol Phys 76:169-75. 2010..Large studies examining the clinical and pathological factors associated with nodal metastasis in minor salivary gland cancer are lacking in the literature... - Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapyShane Lloyd
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520 8040, USA
Am J Clin Oncol 34:76-81. 2011..The effect of adjuvant radiation therapy (RT) on survival in patients with adenoid cystic carcinoma (ACC) is much debated. Studies with large numbers of patients and long follow-up are lacking in the literature... - Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skinJames B Yu
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA
Am J Clin Oncol 33:125-7. 2010..Microcystic adnexal carcinoma (MAC) is a very rare cancer of the skin. It has only been described previously in case reports and small retrospective series... - Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinomaAyal A Aizer
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06510, USA
Radiother Oncol 93:185-91. 2009.... - Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalitiesRoy H Decker
Yale University School of Medicine, New Haven, Connecticut 06520-8040, USA
Oncology (Williston Park) 20:899-905; discussion 905-8, 913. 2006..Additionally, emerging evidence suggests that new modalities, such as stereotactic radiosurgery and radiofrequency ablation, may also be potentially curative treatment alternatives. These modalities are addressed in part 2... - Stereotactic body radiotherapy for central lung tumorsBryan P Rowe
Department of Therapeutic Radiology, Yale University School of Medicine, Yale Cancer Center, New Haven, Connecticut 06520, USA
J Thorac Oncol 7:1394-9. 2012..The primary purpose of this study was to assess toxicity in patients with central lesions treated with SBRT at our institution, the majority of whom were treated with four fractions... - A significant decrease in rectal volume and diameter during prostate IMRTNicole S Anderson
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA
Radiother Oncol 98:187-91. 2011..To record changes in rectal volume (RV) and diameter (RD) of patients with prostate adenocarcinoma prior to and at an interim period during radiotherapy, which could potentially affect treatment toxicity and tumor control... - Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancerJames B Yu
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA
Int J Radiat Oncol Biol Phys 83:e101-7. 2012..We performed a retrospective cohort study of Medicare patients treated with IMRT compared with standard RT to assess outcomes in national practice... - Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005John W Colberg
Departments of Surgery, Yale University School of Medicine, New Haven, CT 06520, USA
Cancer J 13:229-32. 2007.... - The role of postoperative radiation therapy (PORT) in the treatment of extrahepatic bile duct cancer: a surveillance, epidemiology, and end results (SEER) population-based investigationJames B Yu
Department of Therapeutic Radiology, Yale School of Medicine, HRT 133, 333 Cedar St, New Haven, CT 06520, USA
J Gastrointest Cancer 39:11-21. 2008..Extrahepatic bile duct cancers (EBDC) are aggressive cancers for which the importance of the use of postoperative radiation therapy (PORT) in potentially curative cases remains the subject of clinical investigation... - Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the Surveillance, Epidemiology, and End Results databaseJames B Yu
Department of Therapeutic Radiology, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06520, USA
J Clin Oncol 26:1483-8. 2008..The primary intention of the analysis of the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) database was to report epidemiologic information and overall survival of patients with PCLPD... - Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencingAzeet Narayan
Department of Therapeutic Radiology, Yale University, New Haven, Connecticut, USA
Cancer Res 72:3492-8. 2012..Our findings suggest that the deep sequencing approach described here may be applied to the development of a practical diagnostic test that measures tumor-derived DNA levels in blood... - Nutritional support of patients undergoing radiation therapy for head and neck cancerJoseph M Colasanto
Yale University School of Medicine, USA
Oncology (Williston Park) 19:371-9; discussion 380-2, 387. 2005..Nutritional directives are best evaluated through multidisciplinary efforts, including input from the patient as well as members of the nursing, nutritionist, and medical staff... - Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapyRoy H Decker
Yale University School of Medicine New Haven, Connecticut 06520-8040, USA
Oncology (Williston Park) 20:727-36. 2006..Additionally, emerging evidence suggests that new modalities, such as stereotactic radiosurgery and radiofrequency ablation, may also be potentially curative treatment alternatives. These modalities will be addressed in part 2...